When overexpressed, MEIS1 is able to transform tumour suppressor-deficient mouse cells in the absence of other oncogenes4 and to accelerate the occurrence of HoxA9-dependent Acute Myeloid Leukemia (AML)18–20. This evidence concerns the gene HOXA9 and acute myeloid leukemia.